A new programme to close the gap for Black men with PCa was announced by Prostate Cancer Research in August ’23. See more here  In partnership with Movember, Prostate Cancer UK is funding a study to help find out why Black men are at higher risk of PCa than other ethnic groups. More here  And Prostate Cancer Research announced an initial £875k investment in finding answers to Black men’s higher risks of diagnosis and death. Black men are twice as likely to get PCa and 2.5 times more likely to die from it than White men. Five new projects launched to specifically tackle this inequity. More here

Prostate Cancer Research has launched a website to empower people living with PCa to make better treatment decisions. Since launch there have been almost 100,000 visitors to the site. You can sign up here to share your experiences on The Infopool. And the Predict Prostate web tool helps you make decisions about PCa treatment.

A hunt is on for 14,000 men who it’s estimated haven’t started PCa treatment due to the pandemic (Feb ’22). More here. Men are asked to answer three quick questions at this risk checker: The ‘Find the 14,000 men’ campaign by Prostate Cancer UK has been nominated for the NHS Communinications Initiative of the Year Award at the 2022 Health Service Journal Awards (Aug ’22).

A new radiation treatment was approved by the US FDA in March for certain patients with advanced PCa. It has been shown to help patients with advanced PCa live longer and maintain quality of life (Mar ’22). See more here

Ryan Edginton told us about the Raman Nanotheranostics (RaNT) team who are developing a new, all-in-one technology capable of diagnosing and treating cancers using a single device. See the video here

Screening for PCa could be possible within five years, says a leading UK expert  (Dec ’21). See more here

The Oxford-Astra Zeneca Covid vaccine technology has been used to design a jab that could treat cancer (Sept ’21). Sky News

Advanced PCa patients can take enzalutamide or abiraterone at home instead of going into hospital for chemotherapy, NHS England says. It will relieve pressure on the NHS. The drugs are smarter, kinder treatments and could extend the lives of many more men, it’s said (May ’20). More here. And a new treatment is being tested that could extend the lives of men with advanced prostate cancer, by killing cancer in the prostate despite the disease having spread. The nationwide Atlanta trial, at Imperial College London, was recruiting 918 newly-diagnosed men. More here

Scientists have created a “Trojan horse” that sneaks nanoparticles into cancer cells and causes them to self-destruct. The research is still in its early days, but the new method has already proved to be effective at killing cancer cells in a petri dish and reducing tumour growth in mice. See more

A Bristol man is the first NHS patient to have a device implanted which can reduce the side effects of radiotherapy by 70% (see more here). And a trial to spare the nerves around the prostate during surgery is being held at Southmead Hospital. If successful, it will reduce the risk of erectile disfunction and will be available throughout England.